Compare TIGO & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIGO | DVA |
|---|---|---|
| Founded | 1990 | 1994 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Misc Health and Biotechnology Services |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.2B |
| IPO Year | 1994 | 1995 |
| Metric | TIGO | DVA |
|---|---|---|
| Price | $58.73 | $104.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $49.56 | ★ $145.00 |
| AVG Volume (30 Days) | ★ 1.1M | 799.0K |
| Earning Date | 02-26-2026 | 02-12-2026 |
| Dividend Yield | ★ 5.11% | N/A |
| EPS Growth | ★ 601.37 | 5.63 |
| EPS | 6.46 | ★ 9.76 |
| Revenue | $5,594,000,000.00 | ★ $13,317,965,000.00 |
| Revenue This Year | $0.65 | $6.50 |
| Revenue Next Year | $15.42 | $2.97 |
| P/E Ratio | ★ $9.06 | $10.73 |
| Revenue Growth | N/A | ★ 5.14 |
| 52 Week Low | $25.50 | $101.00 |
| 52 Week High | $58.85 | $179.60 |
| Indicator | TIGO | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 65.32 | 29.58 |
| Support Level | $49.40 | $101.00 |
| Resistance Level | $51.60 | $106.38 |
| Average True Range (ATR) | 2.05 | 3.05 |
| MACD | 0.18 | -0.77 |
| Stochastic Oscillator | 99.89 | 26.82 |
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to acquire Telefonica's operations in Ecuador and Uruguay.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.